Cytogenix (fka CYGX)

[gutaquest]

david, Your assessment of the present status of CYGX is certainly a realistic one IMO.

If CYGX has not raised any capital or made a large synDNA shipment since the 3Qtr financial report, they are out of cash now. That means payroll is not being met and all of the other essentials are backing up as accounts payable.

The cash burn rate is around $1 million per quarter.

Malcolm and the board of directors are on the spot and have to deliver a financial package that will allow CYGX to bring synDNA to market. The package I would be trying to close on would be in the $15M to $30M range. This would allow some IND support using synDNA as the mfg process.

I am a stockholder but at a risk level that I can well afford with cash available to buy if the financial fog clears.

Gutaquest